Insider Transactions in Q2 2020 at Avidity Biosciences, Inc. (RNA)
Insider Transaction List (Q2 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 16
2020
|
Cormorant Asset Management, LP |
BUY
Open market or private purchase
|
Indirect |
300,000
+10.66%
|
$5,400,000
$18.0 P/Share
|
|
Jun 16
2020
|
Cormorant Asset Management, LP |
BUY
Conversion of derivative security
|
Indirect |
2,214,545
+50.0%
|
-
|
|
Jun 16
2020
|
Rtw Investments, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
950,000
+19.21%
|
$17,100,000
$18.0 P/Share
|
|
Jun 16
2020
|
Rtw Investments, LP > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
3,045,000
+50.0%
|
-
|
|
Jun 16
2020
|
Lilly & CO Eli |
BUY
Conversion of derivative security
|
Direct |
2,169,396
+50.0%
|
-
|